Lung cancer patients live longer with immune therapy
Monday, 16 April 2018 For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.
According to a new report, lung cancer patients live longer while on immune therapy. Using a combination of immunotherapy drugs, doctors found that pre-treating lung cancer patients before surgery can help eat away at tumors, while helping patients recover from the affects of chemotherapy. A lung...
A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives, potentially aiding the Swiss company's bid to win approval in... Reuters - HealthAlso reported by •GlobeNewswire •Science Daily